SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001214659-13-001903
Filing Date
2013-04-05
Accepted
2013-04-05 16:40:51
Documents
3
Period of Report
2013-05-16
Effectiveness Date
2013-04-05

Document Format Files

Seq Description Document Type Size
1 f43131def14a.htm DEF 14A 1409194
2 antheralogo.jpg GRAPHIC 20925
3 truexsig.jpg GRAPHIC 4626
  Complete submission text file 0001214659-13-001903.txt   1445680
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34637 | Film No.: 13746424
SIC: 2834 Pharmaceutical Preparations